Evaxion AS (EVAX)
3.76
-0.50
(-11.74%)
USD |
NASDAQ |
Mar 16, 12:28
Evaxion EPS Diluted (Quarterly) : 0.7227 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Novo Nordisk A/S | 0.9419 |
| Ascendis Pharma A/S | -0.6364 |
| DBV Technologies SA | -1.207 |
| Cellectis SA | 0.0058 |
| Akari Therapeutics Plc | -0.1947 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 4.597M |
| Revenue (Quarterly) | 7.458M |
| Total Expenses (Quarterly) | 2.861M |
| Enterprise Value | 24.96M |
| Profit Margin (Quarterly) | 61.64% |
| Earnings Yield | -92.62% |
| Normalized Earnings Yield | -92.61 |